https://www.ispor.org/vih-articles/Volume-14--Issue-7/PCN101-A-Cost-Effectiveness-Analysis-for-Second-Line-Treatment-of-Relapsed-Refractory-(RR)-Multiple-Myeloma-(MM)-in-the-United-Kingdom
PCN101 A Cost-Effectiveness Analysis for Second-Line Treatment of Relapsed/Refractory (RR) Multiple...